SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-056466
Filing Date
2012-08-09
Accepted
2012-08-09 14:36:38
Documents
12
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-13915_110q.htm 10-Q 745540
2 EX-10.1 a12-13915_1ex10d1.htm EX-10.1 86113
3 EX-31.1 a12-13915_1ex31d1.htm EX-31.1 9594
4 EX-31.2 a12-13915_1ex31d2.htm EX-31.2 9602
5 EX-32.1 a12-13915_1ex32d1.htm EX-32.1 4467
6 EX-32.2 a12-13915_1ex32d2.htm EX-32.2 4483
  Complete submission text file 0001104659-12-056466.txt   5547190

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT sgyp-20120630.xml EX-101.INS 733465
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20120630.xsd EX-101.SCH 47221
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20120630_cal.xml EX-101.CAL 61461
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20120630_def.xml EX-101.DEF 260204
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sgyp-20120630_lab.xml EX-101.LAB 695806
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20120630_pre.xml EX-101.PRE 341086
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35268 | Film No.: 121019894
SIC: 2834 Pharmaceutical Preparations